Kalinowski L - Search Results

1

Pathogenesis of psoriasis in the "omic" era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis.

Owczarczyk-Saczonek A, Purzycka-Bohdan D, Nedoszytko B, Reich A, Szczerkowska-Dobosz A, Bartosiñska J, Batycka-Baran A, Czajkowski R, Dobrucki IT, Dobrucki LW, Górecka-Sokołowska M, Janaszak-Jasiecka A, Kalinowski L, Krasowska D, Radulska A, Reszka E, Samotij D, Słominski A, Słominski R, Sobalska-Kwapis M, Stawczyk-Macieja M, Strapagiel D, Szczêch J, Żmijewski M, Nowicki RJ. Owczarczyk-Saczonek A, et al. Among authors: kalinowski l. Postepy Dermatol Alergol. 2020 Aug;37(4):452-467. doi: 10.5114/ada.2020.98284. Epub 2020 Sep 2. Postepy Dermatol Alergol. 2020. PMID: 32994764 Free PMC article. Review.

2

The protective role of nitric oxide in the brain ischemia.

Dobrucki LW, Kalinowski L, Uracz W, Malinski T. Dobrucki LW, et al. Among authors: kalinowski l. J Physiol Pharmacol. 2000 Dec;51(4 Pt 1):695-703. J Physiol Pharmacol. 2000. PMID: 11192942 Free article.

3

Nitric oxide measurements during endotoxemia.

Brovkovych V, Dobrucki LW, Brovkovych S, Dobrucki I, Kalinowski L, Kiechle F, Malinski T. Brovkovych V, et al. Among authors: kalinowski l. Clin Chem. 2001 Jun;47(6):1068-74. Clin Chem. 2001. PMID: 11375293

4

Cicletanine stimulates nitric oxide release and scavenges superoxide in endothelial cells.

Kalinowski L, Dobrucki IT, Malinski T. Kalinowski L, et al. J Cardiovasc Pharmacol. 2001 Jun;37(6):713-24. doi: 10.1097/00005344-200106000-00009. J Cardiovasc Pharmacol. 2001. PMID: 11392468

5

Statin-stimulated nitric oxide release from endothelium.

Dobrucki LW, Kalinowski L, Dobrucki IT, Malinski T. Dobrucki LW, et al. Among authors: kalinowski l. Med Sci Monit. 2001 Jul-Aug;7(4):622-7. Med Sci Monit. 2001. PMID: 11433186

6

Nitric oxide as a second messenger in parathyroid hormone-related protein signaling.

Kalinowski L, Dobrucki LW, Malinski T. Kalinowski L, et al. J Endocrinol. 2001 Aug;170(2):433-40. doi: 10.1677/joe.0.1700433. J Endocrinol. 2001. PMID: 11479139

7

Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin.

Kalinowski L, Dobrucki LW, Brovkovych V, Malinski T. Kalinowski L, et al. Circulation. 2002 Feb 26;105(8):933-8. doi: 10.1161/hc0802.104283. Circulation. 2002. PMID: 11864921

8

Cerivastatin potentiates nitric oxide release and enos expression through inhibition of isoprenoids synthesis.

Kalinowski L, Dobrucki IT, Malinski T. Kalinowski L, et al. J Physiol Pharmacol. 2002 Dec;53(4 Pt 1):585-95. J Physiol Pharmacol. 2002. PMID: 12512694 Free article.

9

Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases.

Kalinowski L, Dobrucki IT, Malinski T. Kalinowski L, et al. Circulation. 2004 Jun 1;109(21):2511-7. doi: 10.1161/01.CIR.0000129087.81352.7A. Epub 2004 May 24. Circulation. 2004. PMID: 15159296

10

Elucidating structure-function relationships from molecule-to-cell-to-tissue: from research modalities to clinical realities.

Dobrucki LW, Marsh BJ, Kalinowski L. Dobrucki LW, et al. Among authors: kalinowski l. J Physiol Pharmacol. 2009 Oct;60 Suppl 4:83-93. J Physiol Pharmacol. 2009. PMID: 20083856 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page